Retroviral glycoprotein-mediated immune suppression via the potassium channel KCa3.1 - A new strategy for amelioration of inflammatory bowel diseases

Retroviral glycoprotein-mediated immune suppression via the potassium channel KCa3.1 - A new strategy for amelioration of inflammatory bowel diseases

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 242(2022) vom: 15. Sept., Seite 109081
1. Verfasser: Laska, Magdalena J (VerfasserIn)
Weitere Verfasser: Moeller, Jesper Bonnet, Graversen, Jonas Heilskov, Strøbæk, Dorte, Blomster, Linda, Christophersen, Palle, Bahrami, Shervin
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Immunosuppressive peptides Inflammatory bowel diseases Ion channels Mechanism of action Intermediate-Conductance Calcium-Activated Potassium Channels Potassium Channel Blockers Tumor Necrosis Factor-alpha
Online verfügbar Volltext